Institute of Biomedicine - News

A new study sheds light on the role of diabetes in the cellular and molecular changes underlying Alzheimer's disease (AD).

Individualised and family-based physical activity and dietary counselling considerably slows down the development of insulin resistance.

New sensitive and effective proteomics methods can be applied to identify potential novel drug targets in inflammatory conditions, leukemia and prostate cancer, according to the doctoral dissertation of Joanna Lempiäinen, MSc.

A new study conducted by researchers at the University of Eastern Finland found that the PLCG2-P522R genetic variant, which protects against Alzheimer’s disease, enhances several key functions of immune cells.

Researchers mapped out the immune landscape of haematological malignancies in a dataset covering more than 10,000 patients to identify drug targets and patient groups which could potentially benefit from immunotherapies.